CA2266479C - Vitamin d analogues - Google Patents

Vitamin d analogues Download PDF

Info

Publication number
CA2266479C
CA2266479C CA002266479A CA2266479A CA2266479C CA 2266479 C CA2266479 C CA 2266479C CA 002266479 A CA002266479 A CA 002266479A CA 2266479 A CA2266479 A CA 2266479A CA 2266479 C CA2266479 C CA 2266479C
Authority
CA
Canada
Prior art keywords
compound
mmol
seco
ether
title compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002266479A
Other languages
English (en)
French (fr)
Other versions
CA2266479A1 (en
Inventor
Martin John Calverley
Henrik Pedersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of CA2266479A1 publication Critical patent/CA2266479A1/en
Application granted granted Critical
Publication of CA2266479C publication Critical patent/CA2266479C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002266479A 1996-10-30 1997-10-27 Vitamin d analogues Expired - Lifetime CA2266479C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9622590.9 1996-10-30
GBGB9622590.9A GB9622590D0 (en) 1996-10-30 1996-10-30 Chemical compounds
PCT/DK1997/000472 WO1998018759A1 (en) 1996-10-30 1997-10-27 Vitamin d analogues

Publications (2)

Publication Number Publication Date
CA2266479A1 CA2266479A1 (en) 1998-05-07
CA2266479C true CA2266479C (en) 2008-09-23

Family

ID=10802170

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002266479A Expired - Lifetime CA2266479C (en) 1996-10-30 1997-10-27 Vitamin d analogues

Country Status (21)

Country Link
US (1) US6310226B1 (ja)
EP (1) EP0937038B1 (ja)
JP (1) JP3907010B2 (ja)
KR (1) KR100526644B1 (ja)
CN (1) CN1107669C (ja)
AT (1) ATE216361T1 (ja)
AU (1) AU722659B2 (ja)
CA (1) CA2266479C (ja)
CZ (1) CZ290933B6 (ja)
DE (1) DE69712086T2 (ja)
DK (1) DK0937038T3 (ja)
ES (1) ES2173425T3 (ja)
GB (1) GB9622590D0 (ja)
HK (1) HK1022298A1 (ja)
HU (1) HUP9904333A3 (ja)
NZ (1) NZ334328A (ja)
PL (1) PL192660B1 (ja)
PT (1) PT937038E (ja)
RO (1) RO120338B1 (ja)
RU (1) RU2183622C2 (ja)
WO (1) WO1998018759A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8860298A (en) * 1997-07-17 1999-02-10 F. Hoffmann-La Roche Ag Dihomo-seco-cholestanes with two unsaturated bones in the side chain
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
SI1730108T1 (sl) * 2004-03-18 2008-08-31 Leo Pharma As Stereoselektivna sinteza analogov vitamina D
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
EP1883626B1 (en) * 2005-04-25 2017-10-11 OPKO Ireland Global Holdings, Ltd. Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3
CA2661546A1 (en) 2006-08-25 2008-02-28 Cougar Biotechnology, Inc. Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
US20080051375A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
CN101505725A (zh) * 2006-08-29 2009-08-12 特瓦制药工业有限公司 包含含维生素D的化合物和皮质类固醇化合物的具有低pH相容性的稳定的药理学活性组合物
EA201691980A1 (ru) 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
US20120184514A1 (en) * 2009-07-01 2012-07-19 Vitamin Derivatives Inc. Vitamin d compounds and methods for preparing same
SG178382A1 (en) 2009-08-14 2012-04-27 Berg Biosystems Llc Vitamin d3 and analogs thereof for treating alopecia
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
JP2019522032A (ja) 2016-07-29 2019-08-08 ヤンセン ファーマシューティカ エヌ．ベー． 前立腺癌の治療方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9223061D0 (en) * 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5449668A (en) 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
JP3228488B2 (ja) 1993-12-24 2001-11-12 株式会社クラレ ２０−エピステロイド誘導体およびその製造方法
JPH0888281A (ja) * 1994-09-19 1996-04-02 Fujitsu Ltd 半導体装置
IL118156A (en) * 1995-05-09 2001-08-26 Duphar Int Res Vitamin d compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT937038E (pt) 2002-09-30
GB9622590D0 (en) 1997-01-08
DE69712086D1 (de) 2002-05-23
EP0937038B1 (en) 2002-04-17
AU722659B2 (en) 2000-08-10
CZ290933B6 (cs) 2002-11-13
HUP9904333A2 (hu) 2000-06-28
CN1107669C (zh) 2003-05-07
WO1998018759A1 (en) 1998-05-07
AU4771797A (en) 1998-05-22
NZ334328A (en) 2000-09-29
HUP9904333A3 (en) 2001-06-28
JP2001503403A (ja) 2001-03-13
PL192660B1 (pl) 2006-11-30
DK0937038T3 (da) 2002-07-15
CA2266479A1 (en) 1998-05-07
US6310226B1 (en) 2001-10-30
ES2173425T3 (es) 2002-10-16
DE69712086T2 (de) 2002-11-14
ATE216361T1 (de) 2002-05-15
EP0937038A1 (en) 1999-08-25
RO120338B1 (ro) 2005-12-30
CZ135899A3 (cs) 1999-07-14
CN1232448A (zh) 1999-10-20
KR20000036233A (ko) 2000-06-26
PL333068A1 (en) 1999-11-08
JP3907010B2 (ja) 2007-04-18
RU2183622C2 (ru) 2002-06-20
KR100526644B1 (ko) 2005-11-08
HK1022298A1 (en) 2000-08-04

Similar Documents

Publication Publication Date Title
CA1340614C (en) Cyclopentano-vitamin d analogs
EP0637299B1 (de) 20-methyl-substituierte vitamin d-derivate
CA2266479C (en) Vitamin d analogues
RU2037484C1 (ru) Аналог витамина д
US5710142A (en) Vitamin D analogues
US6399797B1 (en) Vitamin D analogues
NZ253026A (en) 20-alkynyl-9,10-seco-pregna-5(z),7(e),10(19),17(20)(e)-tetraene (vitamin d) derivatives and pharmaceutical compositions
EP0865428B1 (en) Vitamin d analogues
RU2163234C2 (ru) Аналоги витамина d, способ их получения, диастереоизомер, фармацевтическая композиция
AU719081B2 (en) Vitamin D3 derivatives
KR20010109357A (ko) 비타민 ｄ 동족체 및 이의 약제학적 용도
CA2222785C (en) Vitamin d analogues

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20171027